The research status of immune checkpoint blockade by anti-CTLA4 and anti-PD1/PD-l1 antibodies in tumor immunotherapy in China: A bibliometrics study.

Zhao, Xiaoqin; He, Liangmei; Mao, Kaiyun; Chen, Daming; Jiang, Hongbo; Liu, Zhiping

Zhao, Xiaoqin; He, Liangmei; Mao, Kaiyun; Chen, Daming; Jiang, Hongbo; Liu, Zhiping.

Afiliação

Zhao X; Shanghai Library Institute of Scientific and Technical Information of Shanghai The First Affiliated Hospital of Gannan Medical University Shanghai Information Center for Life Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai School of Basic Medicine, Gannan Medical University Ganzhou Cancer Precision Medicine Engineering Research Center, Ganzhou, Jiangxi, China.

Medicine (Baltimore) ; 97(15): e0276, 2018 Apr.

Article em En | MEDLINE | ID: mdl-29642147

Assuntos

Antígeno B7-H1/imunologia; Bibliometria; Antígeno CTLA-4/imunologia; Imunoterapia; Neoplasias/terapia; Receptor de Morte Celular Programada 1/imunologia; Pesquisa Biomédica; China; Bases de Dados Factuais; Humanos; Imunossupressores/farmacologia; Imunoterapia/métodos; Imunoterapia/estatística & dados numéricos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bibliometria / Antígeno B7-H1 / Antígeno CTLA-4 / Receptor de Morte Celular Programada 1 / Imunoterapia / Neoplasias Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google